Teruki Kobayashi
Okayama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Near-infrared Photoimmunotherapy Targeting Cancer-Associated Fibroblasts in Patient-Derived Xenografts Using a Humanized Anti-Fibroblast Activation Protein Antibody.
Journal: Molecular cancer therapeutics
Published: August 14, 2023
PD-L1-expressing cancer-associated fibroblasts induce tumor immunosuppression and contribute to poor clinical outcome in esophageal cancer.
Journal: Cancer immunology, immunotherapy : CII
Published: June 26, 2023
Fibroblast activation protein-targeted near-infrared photoimmunotherapy depletes immunosuppressive cancer-associated fibroblasts and remodels local tumor immunity.
Journal: British journal of cancer
Published: May 26, 2023
Conventional Cancer Therapies Can Accelerate Malignant Potential of Cancer Cells by Activating Cancer-Associated Fibroblasts in Esophageal Cancer Models.
Journal: Cancers
Published: April 03, 2023
A case of granulocyte-colony-stimulating factor-producing gallbladder cancer with lymph node metastasis together with a literature review.
Journal: Clinical journal of gastroenterology
Published: December 27, 2022
Dual-targeted near-infrared photoimmunotherapy for esophageal cancer and cancer-associated fibroblasts in the tumor microenvironment.
Journal: Scientific reports
Published: June 21, 2022
Overcoming cancer-associated fibroblast-induced immunosuppression by anti-interleukin-6 receptor antibody.
Journal: Cancer immunology, immunotherapy : CII
Published: April 18, 2022
Fibroblast activation protein targeted near infrared photoimmunotherapy (NIR PIT) overcomes therapeutic resistance in human esophageal cancer.
Journal: Scientific reports
Published: August 31, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026